158 related articles for article (PubMed ID: 11404798)
1. Apoptosis and hormonal milieu in ductal system of normal prostate and benign prostatic hyperplasia.
Xia SJ; Xu CX; Tang XD; Wang WZ; Du DL
Asian J Androl; 2001 Jun; 3(2):131-4. PubMed ID: 11404798
[TBL] [Abstract][Full Text] [Related]
2. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
3. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
4. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
[TBL] [Abstract][Full Text] [Related]
5. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
[TBL] [Abstract][Full Text] [Related]
6. Androgen, estrogen, and progesterone receptors in normal and aging prostates.
Srinivasan G; Campbell E; Bashirelahi N
Microsc Res Tech; 1995 Mar; 30(4):293-304. PubMed ID: 7541676
[TBL] [Abstract][Full Text] [Related]
7. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.
Kojima Y; Sasaki S; Oda N; Koshimizu TA; Hayashi Y; Kiniwa M; Tsujimoto G; Kohri K
Prostate; 2009 Oct; 69(14):1521-8. PubMed ID: 19544328
[TBL] [Abstract][Full Text] [Related]
8. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor isoforms in human and rat prostate.
Xia SJ; Hao GY; Tang XD
Asian J Androl; 2000 Dec; 2(4):307-10. PubMed ID: 11202423
[TBL] [Abstract][Full Text] [Related]
10. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
[TBL] [Abstract][Full Text] [Related]
11. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
Lloyd JW; Thomas JA; Mawhinney MG
Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
[TBL] [Abstract][Full Text] [Related]
12. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of caspase-1 in benign hyperplastic prostate tissues].
Deng CH; Zang ZJ; Sun XZ; Huang XH; Wang H; Wang D; Su SH
Zhonghua Nan Ke Xue; 2005 Nov; 11(11):810-2. PubMed ID: 16333955
[TBL] [Abstract][Full Text] [Related]
14. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
[TBL] [Abstract][Full Text] [Related]
15. Clinical study on estramustine binding protein (EMBP) in human prostate.
Shiina H; Igawa M; Ishibe T
Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085
[TBL] [Abstract][Full Text] [Related]
16. Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH).
Monti S; Di Silverio F; Toscano V; Martini C; Lanzara S; Varasano PA; Sciarra F
J Androl; 1998; 19(4):428-33. PubMed ID: 9733145
[TBL] [Abstract][Full Text] [Related]
17. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
Krieg M; Nass R; Tunn S
J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
[TBL] [Abstract][Full Text] [Related]
18. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.
Heracek J; Hampl R; Hill M; Starka L; Sachova J; Kuncova J; Eis V; Urban M; Mandys V
Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496
[TBL] [Abstract][Full Text] [Related]
19. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
Simanainen U; McNamara K; Gao YR; Handelsman DJ
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
[TBL] [Abstract][Full Text] [Related]
20. Prostatic cancer/benign prostatic hypertrophy. Subcellular distribution of estradiol/androgen receptors.
Salazar EL; Mercado E; Calzada L
Arch Androl; 2005; 51(2):135-9. PubMed ID: 15804868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
